Please ensure Javascript is enabled for purposes of website accessibility

Why Invitae Stock Tumbled Today

By Keith Speights - Updated Mar 24, 2021 at 3:31PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Blame a broader market sell-off of growth stocks.

What happened

Shares of Invitae (NVTA -6.78%) were tumbling 10.9% as of 3:11 p.m. EDT on Wednesday. There weren't any new developments that explained the decline. Instead, the stock appeared to be dragged down in a broader sell-off of growth stocks.

So what

It's best to ignore short-term volatility, especially when there isn't a clear underlying cause. Investors are better off focusing on Invitae's long-term prospects. And those prospects still look pretty good.

DNA with a bright light shining in the background

Image source: Getty Images.

The medical genetics company appears to have recovered from a temporary growth blip caused by the pandemic. Revenue and testing volume roared back in the fourth quarter of 2020. Key acquisitions of ArcherDX and One Codex have enabled Invitae to expand its product offerings.

Invitae continues to estimate its total addressable market at more than $150 billion. The company has an especially big opportunity in providing genetic testing to individuals 65 and older with significant potential for growth in areas such as cancer therapy selection.  

Now what

Don't be surprised if the healthcare stock rebounds quickly. Invitae's partnerships with biopharmaceutical companies could especially make a difference in the not-too-distant future. The company signed 89 new deals with biopharma companies last year, including 30 in the fourth quarter alone.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Invitae Stock Quote
Invitae
NVTA
$3.44 (-6.78%) $0.25

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
334%
 
S&P 500 Returns
117%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/25/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.